CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: Based on our understanding that CML patients harbor a consistently detectable population of quiescent Ph+ and Bcr-Abl+ CD34+ cells which are associated with constitutive activation of Stat5 and CrkL [21], we examined the expression profile of these CML-driving proteins in the K562 cells.